Carrier Screening Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc.,

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2174

The Business Research Company offers in-depth market insights through Carrier Screening Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The carrier screening market size has grown rapidly in recent years. It will grow from $2.31 billion in 2023 to $2.7 billion in 2024 at a compound annual growth rate (CAGR) of 16.8%. The growth in the historic period can be attributed to increasing genetic disorders awareness, rising maternal age, family planning and pregnancy awareness, prevention of genetic diseases, public health initiatives, increased focus on inherited conditions..

The carrier screening market size is expected to see rapid growth in the next few years. It will grow to $4.91 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to precision medicine advancements, expanded panel offerings, consumer genomics and direct-to-consumer testing, focus on rare and ultra-rare diseases, government and insurance support, pharmacogenomics integration.. Major trends in the forecast period include advancements in genetic technologies, integration with prenatal testing, rise in personalized medicine, counseling and education services, ethical and legal considerations..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp

Market Segmentation:
The carrier screening market covered in this report is segmented -

1) By Type: Expanded Carrier Screening, Targeted Disease Carrier Screening
2) By Medical Condition: Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions
3) By Technology: DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies
4) By End User: Hospitals, Reference Laboratories, Physician Offices and Clinics, Other End Users

Major Driver - Rising Incidence Of Fetal Chromosomal Abnormalities Fuels Growth In The Carrier Screening Market
An increase in fetal chromosomal abnormalities and genetic disorders is expected to propel the growth of the carrier screening market going forward. Fetal chromosomal abnormalities refer to a fetus with an abnormal number of chromosomes, an abnormal quantity of DNA inside a chromosome. Prenatal testing for chromosomal abnormalities is intended to provide an accurate assessment of a patient's risk of carrying a fetus with a chromosomal disorder. For instance, in February 2022, according to estimates by the World Health Organization, a Switzerland-based global health agency, birth defects cause 240 000 newborns to pass away in the first 28 days of life each year. An additional 170,000 children between the ages of 1 month and 5 years die as a result of birth defects. Moreover, in March 2022, according to an article published by the Government of United Nations, Down syndrome is estimated to affect 1 in 1,000 to 1 in 1,100 live births worldwide. Every year, between 3,000 and 5,000 children are born with this chromosome disorder. Therefore, an increase in fetal chromosomal abnormalities and genetic disorders is driving the growth of the carrier screening market.

Competitive Landscape:
Major companies operating in the carrier screening market report are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Genealogy by Genetics Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., 23andMe Holding Co., REALM IDx Inc., Associated Regional and University Pathologists Inc., Genedx LLC, Genomic Health Inc., GenPath Consultants And Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., OraSure Technologies Inc., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

Top Trend - Blueprint Genetics Introduces Screening Tests Family
Major companies operating in the carrier screening market are focusing on product developments, such as screening tests family, to sustain their position in the market. Screening tests are medical procedures or tests performed on individuals who do not exhibit any symptoms of a particular disease or condition. For instance, in June 2023, Blueprint Genetics, a Finland-based company specializing in genetic testing and diagnostics, introduced a new offering called the Screening Tests family. This product is designed for specific purposes such as pregnancy, family planning, and comprehensive health checks for asymptomatic individuals. The objective is to identify any heightened risks, empowering individuals to make informed decisions regarding family planning and health. Blueprint Genetics aims to offer actionable information that enables proactive choices based on the available options, emphasizing a commitment to supporting individuals in making informed decisions about their future well-being.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Carrier Screening Market Characteristics
3. Carrier Screening Market Trends And Strategies
4. Carrier Screening Market - Macro Economic Scenario
5. Carrier Screening Market Size And Growth
…..
27. Carrier Screening Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.